bpc 157 dosage for tendon healing BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or bpc 157 for tendon repair
Description
However, because Bells palsy also impairs control of the eyelids, tears may spill out of the affected eye giving the appearance of over-tearing
Any over-activity or inhibition of these systems may lead to lesions in different organs
This happens more often in the thigh than the abdomen because the thigh has a denser vascular network in some areas
This formulation contains a measured peptide solution housed within a spray-based delivery system
